Cellectis S.A.
CLLS
$3.24
-$0.08-2.41%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -9.49% | -44.44% | |||
| Total Other Revenue | -5.42% | -2.15% | |||
| Total Revenue | -8.53% | -38.17% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -8.53% | -38.17% | |||
| SG&A Expenses | 2.67% | 16.41% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -360.32% | -119.69% | |||
| Total Operating Expenses | -7.00% | 10.68% | |||
| Operating Income | 6.54% | -45.05% | |||
| Income Before Tax | -23.00% | 33.74% | |||
| Income Tax Expenses | -45.65% | 110.87% | |||
| Earnings from Continuing Operations | -22.82% | 32.50% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -22.82% | 32.50% | |||
| EBIT | 6.54% | -45.05% | |||
| EBITDA | 7.86% | -44.37% | |||
| EPS Basic | -22.69% | 32.63% | |||
| Normalized Basic EPS | -22.78% | 33.85% | |||
| EPS Diluted | -22.69% | 32.63% | |||
| Normalized Diluted EPS | -22.78% | 33.85% | |||
| Average Basic Shares Outstanding | 0.12% | 0.20% | |||
| Average Diluted Shares Outstanding | 0.12% | 0.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||